Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2002
A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen
James A Bennett, Fassil B Mesfin, Thomas T Andersen, et al.
Advances in Experimental Medicine and Biology
|
May 24, 2008
Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk
Herbert I Jacobson, Nicole Lemanski, Amithi Narendran, et al.
Microbial Biotechnology
|
July 3, 2021
Enhanced hydrogenation catalyst synthesized by Desulfovibrio desulfuricans exposed to a radio frequency magnetic field
Lynne E Macaskie, John Collins, Iryna P Mikheenko, et al.
Breast Cancer Research and Treatment
|
March 16, 2006
AFPep: an anti-breast cancer peptide that is orally active
James A Bennett, Lori DeFreest, Ikenna Anaka, et al.
Outcomes Management
|
December 26, 2002
Evaluating process changes in a pediatric hospital medication system
Barbara L Marino, Patricia Branowicki, James A Bennett, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 26, 2009
A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy
Herbert I Jacobson, Nicole Lemanski, Anu Agarwal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 21, 2012
Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis
Rajender K Motiani, Xuexin Zhang, Kelly E Harmon, et al.
Oncology Reports
|
June 11, 2009
AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats
Amanda M Tower, Andrea Trinward, Katie Lee, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study
Mario Uccello, Abigail L Gee, James A Bennett, et al.
Clinical Medicine (London, England)
|
January 25, 2023
Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists
Rippie K Tutika, James A Bennett, Jean Abraham, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
February 7, 2002
A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen
James A Bennett, Fassil B Mesfin, Thomas T Andersen, et al.
Advances in Experimental Medicine and Biology
|
May 24, 2008
Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk
Herbert I Jacobson, Nicole Lemanski, Amithi Narendran, et al.
Microbial Biotechnology
|
July 3, 2021
Enhanced hydrogenation catalyst synthesized by Desulfovibrio desulfuricans exposed to a radio frequency magnetic field
Lynne E Macaskie, John Collins, Iryna P Mikheenko, et al.
Breast Cancer Research and Treatment
|
March 16, 2006
AFPep: an anti-breast cancer peptide that is orally active
James A Bennett, Lori DeFreest, Ikenna Anaka, et al.
Outcomes Management
|
December 26, 2002
Evaluating process changes in a pediatric hospital medication system
Barbara L Marino, Patricia Branowicki, James A Bennett, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
November 26, 2009
A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy
Herbert I Jacobson, Nicole Lemanski, Anu Agarwal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 21, 2012
Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis
Rajender K Motiani, Xuexin Zhang, Kelly E Harmon, et al.
Oncology Reports
|
June 11, 2009
AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats
Amanda M Tower, Andrea Trinward, Katie Lee, et al.
Current Oncology (Toronto, Ont.)
|
June 25, 2026
Metastatic Tumour Burden as Prognostic Factor in Nivolumab-Treated Metastatic Renal Cell Carcinoma: An Exploratory Study
Mario Uccello, Abigail L Gee, James A Bennett, et al.
Clinical Medicine (London, England)
|
January 25, 2023
Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists
Rippie K Tutika, James A Bennett, Jean Abraham, et al.
Page
of 4